sodium-hypochlorite has been researched along with Skin-Diseases--Bacterial* in 5 studies
1 review(s) available for sodium-hypochlorite and Skin-Diseases--Bacterial
Article | Year |
---|---|
Antibiotic therapy in the management of atopic dermatitis.
Atopic dermatitis (AD), also known as atopic eczema, is a syndrome characterized by a chronic eczematous dermatitis, with associated pruritus, characteristic age-specific morphology and distribution of lesions and recurrent nature. Secondary infections in patients with AD are very common and difficult to treat. S. aureus colonizes almost all eczematous lesions in atopic patients and releases several super-antigens and exotoxins (i.e., toxic shock syndrome toxin-1, enterotoxins A-D, etc.), which sustain inflammatory reactions and promote tachyphylaxis. The topical antibiotics most commonly prescribed for mild/moderate secondary infections are gentamicin, fusidic acid and mupirocine. This article reviews existing therapeutic options and provides guidance for the management of secondary skin infection among patients with AD. Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Child; Dermatitis, Atopic; Disease Susceptibility; Disinfectants; Drug Resistance, Microbial; Drug Therapy, Combination; Fusidic Acid; Humans; Skin; Skin Diseases, Bacterial; Sodium Hypochlorite; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Superinfection | 2015 |
4 other study(ies) available for sodium-hypochlorite and Skin-Diseases--Bacterial
Article | Year |
---|---|
Comparison of bleach, acetic acid, and other topical anti-infective treatments in pediatric atopic dermatitis: A retrospective cohort study on antibiotic exposure.
Skin infection is common in atopic dermatitis (AD), often necessitating treatment with systemic antibiotics. Topical adjunctive therapies such as dilute bleach baths are increasingly recommended, and topical dilute acetic acid (AA) has not been widely studied. The objective of this study was to evaluate whether various topical anti-infective bathing recommendations were associated with decreased systemic antibiotic exposure in pediatric AD, as well as evaluate topical anti-infective recommendations over time within our institution.. Clinical data were extracted from charts of pediatric patients from 1/1/2000 to 12/31/2005 and 1/1/2009 to 12/31/2014 who visited outpatient dermatology clinics at Mayo Clinic, Rochester, a tertiary referral center. Recommendations for topical anti-infectives (dilute AA, dilute bleach, other, or none) at any time after patient had clinically proven or suspected AD superinfection were recorded as exposures to topical anti-infective. Primary outcome was the number of systemic antibiotic courses in a 1-year period.. Of 1111 patients with AD, 753 met inclusion criteria (303 in 2000-2005; 450 in 2009-2014). Of these, 351 (46.6%) had culture-proven or clinically suspected superinfection. Topical anti-infective recommendations increased between the time periods (23.3% to 79.2%; P < 0.001) and number of courses of systemic antibiotics decreased (1.9 per year vs 1.5 per year, P = 0.010). Number of systemic antibiotic courses did not differ between those who received bathing recommendations and those who did not, nor between different anti-infective groups (P = 0.398).. Practice behaviors have changed, and topical anti-infectives are now commonly recommended. Neither dilute AA nor bleach baths were associated with fewer subsequent exposures to systemic antibiotics in the treatment of pediatric AD. Topics: Acetic Acid; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents, Local; Child; Child, Preschool; Cohort Studies; Dermatitis, Atopic; Female; Humans; Infant; Male; Practice Guidelines as Topic; Retrospective Studies; Skin; Skin Diseases, Bacterial; Sodium Hypochlorite | 2019 |
The use of a modified Dakin's solution (sodium hypochlorite) in the treatment of Vibrio vulnificus infection.
We report the first clinical use of a modified Dakin's solution (0.025% sodium hypochlorite [NaOCl]) to halt the progress of severe cutaneous Vibrio vulnificus infection in a critically ill patient. The regimen used arose from an initial in vitro study designed to examine the sensitivity of Vibrio species to topical antimicrobial agents. Twenty-eight wound isolates were tested against the following eight topical preparations: silver sulfadiazine (Silvadene), nitrofurazone, mupirocin ointment (Bactroban), polymyxin B/bacitracin, mafenide acetate (Sulfamylon), nystatin/Silvadene, nystatin/polymyxin B/bacitracin, and 0.025% NaOCl solution. The results showed that V vulnificus, along with the other 18 Vibrio species tested, was most sensitive to the modified NaOCl solution. Topics: Administration, Cutaneous; Aged; Anti-Infective Agents, Local; Cellulitis; Critical Illness; Humans; Male; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Sodium Hypochlorite; Vibrio; Vibrio Infections | 1999 |
Modified Dakin's solution for cutaneous vibrio infections.
Vibrio species, specifically Vibrio vulnificus, are known to be endemic to warm saltwater environments. As a human pathogen they are capable of causing severe, progressive, necrotizing infections. The lesions are bullous in nature and often require wide surgical debridement due to the aggressiveness of this organism. The literature supports prophylactic antibiotic therapy for those with preexisting hepatic dysfunction or immunocompromise. The authors routinely implement prophylactic antibiotic coverage with doxycycline 100 mg every 12 hours for vibrio in patients with wounds exposed to or acquired in saltwater. In addition, they institute topical therapy with 0.025% sodium hypochlorite solution (modified Dakin's), based on their in vitro study of vibrio sensitivity to antimicrobials. Over the past 2 years, the authors have treated 10 patients with this protocol for cutaneous vibrio infections confirmed by quantitative cultures. None of these patients experienced progression of infection requiring operative debridement-contrary to the aggressive nature of this organism documented in other reports. Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Disinfectants; Doxycycline; Female; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Sodium Hypochlorite; Vibrio Infections | 1999 |
Loofah sponges as reservoirs and vehicles in the transmission of potentially pathogenic bacterial species to human skin.
Loofah sponges are natural products used as exfoliative beauty aids. As a consequence of tracing a case of Pseudomonas aeruginosa folliculitis to a contaminated loofah sponge, we assessed the role of loofah sponges in supporting the growth of a wide variety of bacterial species. Our data show growth enhancement of sterile loofah fragments for numerous gram-negative (Pseudomonas, Xanthomonas, and Klebsiella) and gram-positive (Enterococcus and group B Streptococcus) species of human and environmental origin. Furthermore, hydrated new, unused loofah sponges undergo a shift in bacterial flora from sparse colonies of Bacillus spp. and Staphylococcus epidermidis to a predominantly gram-negative flora. The growth-promoting potential of loofah sponges (and other exfoliatives) can be further augmented by desquamated epithelial cells entrapped in the loofah fibrous matrix. Therefore, as loofah sponges (and other exfoliatives) can serve as a reservoir and a vehicle for the transmission of potentially pathogenic species to the human skin, we recommend their decontamination with hypochlorite (10%) bleach at regular intervals. Topics: Bacteria; Baths; Cellulose; Disease Reservoirs; Disinfection; Equipment Contamination; Folliculitis; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pseudomonas Infections; Skin Diseases, Bacterial; Sodium Hypochlorite | 1994 |